Based on the distinct impact of TREM-1 on hypercholesterolemia-induced monopoiesis and its highly upregulated expression within aortic lesions, we propose TREM-1 as an attractive myeloid cell-specific target for attenuating the chronic inflammatory process in atherosclerosis. Here, TREM1 is linked to Hypercholesterolemia.